热景生物(688068.SH)2023年度净利润3016.12万元同比大幅下降96.81%

智通财经网02-28

热景生物(688068.SH)披露2023年度业绩快报，报告期内，公司实现营业收入54,114.67万元，与去年同期相比下降84.78%;实现归属于母公司所有者的净利润3016.12万元，与去年同期相比下降96.81%。2023年度国内外抗击新冠疫情取得巨大胜利，新冠抗原检测试剂已非抗疫急需物资，相关业务范围恢复至疫情前。公司营业收入较去年出现了较大下降，导致归属于母公司所有者的净利润和归属于...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2414328815?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-28 20:18","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2414328815","market":"hk","top_or_hot":-1,"title":"热景生物(688068.SH)2023年度净利润3016.12万元 同比大幅下降96.81%","media":"智通财经网","content":"<div>\n<p>热景生物(688068.SH)披露2023年度业绩快报，报告期内，公司实现营业收入54,114.67万元，与去年同期相比下降84.78%;实现归属于母公司所有者的净利润3016.12万元，与去年同期相比下降96.81%。2023年度国内外抗击新冠疫情取得巨大胜利，新冠抗原检测试剂已非抗疫急需物资，相关业务范围恢复至疫情前。公司营业收入较去年出现了较大下降，导致归属于母公司所有者的净利润和归属于...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakraum0302283.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>热景生物(688068.SH)2023年度净利润3016.12万元 同比大幅下降96.81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n热景生物(688068.SH)2023年度净利润3016.12万元 同比大幅下降96.81%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-28 20:18 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakraum0302283.shtml><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>热景生物(688068.SH)披露2023年度业绩快报，报告期内，公司实现营业收入54,114.67万元，与去年同期相比下降84.78%;实现归属于母公司所有者的净利润3016.12万元，与去年同期相比下降96.81%。2023年度国内外抗击新冠疫情取得巨大胜利，新冠抗原检测试剂已非抗疫急需物资，相关业务范围恢复至疫情前。公司营业收入较去年出现了较大下降，导致归属于母公司所有者的净利润和归属于...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakraum0302283.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688068","symbol_name":"热景生物","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakraum0302283.shtml","article_id":"2414328815","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakraum0302283.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2414328815","pubTimestamp":1709122680,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"热景生物披露2023年度业绩快报，报告期内，公司实现营业收入54,114.67万元，与去年同期相比下降84.78%;实现归属于母公司所有者的净利润3016.12万元，与去年同期相比下降96.81%。报告期内，公司贯彻执行从诊断到治疗业务的全研发战略布局，加大在生物创新药及创新诊断领域的人员、设备和技术投入，持续不断的推出新产品和储备发展潜力，2023年度累计研发投入13,334.83万元，占营业收入的比例达24.64%。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"688068":"热景生物"},"translate_title":"The net profit of Hot View Bio (688068. SH) in 2023 was 30.1612 million yuan, down 96.81% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688068":1},"content_text":"热景生物(688068.SH)披露2023年度业绩快报，报告期内，公司实现营业收入54,114.67万元，与去年同期相比下降84.78%;实现归属于母公司所有者的净利润3016.12万元，与去年同期相比下降96.81%。2023年度国内外抗击新冠疫情取得巨大胜利，新冠抗原检测试剂已非抗疫急需物资，相关业务范围恢复至疫情前。公司营业收入较去年出现了较大下降，导致归属于母公司所有者的净利润和归属于母公司所有者的扣除非经常性损益的净利润出现大幅下降。报告期内，公司贯彻执行从诊断到治疗业务的全研发战略布局，加大在生物创新药及创新诊断领域的人员、设备和技术投入，持续不断的推出新产品和储备发展潜力，2023年度累计研发投入13,334.83万元，占营业收入的比例达24.64%。但由于创新业务研发周期长、投入大，短期内还无法为上市公司贡献业绩，也影响了上市公司利润。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2414328815"}

热景生物(688068.SH)2023年度净利润3016.12万元 同比大幅下降96.81%

精彩评论

热景生物(688068.SH)2023年度净利润3016.12万元同比大幅下降96.81%